stars 1 stars 2 stars 3

At Rivercyte, we combine years of experience in deformability cytometry, deep learning, hardware, and software development to establish a novel technology for rapid physical phenotyping of cells. Our core technology is based on a microfluidic chip through which cells flow and deform. Using high-speed microscopy, an image of each cell is captured and analyzed with AI-based software. Ultimately, our technology will be an invaluable tool for detecting anomalies in cell samples and for automating routine analytical procedures in life science and medicine.

Rivercyte Questions

Martin Kräter is the CEO at Rivercyte GmbH of Rivercyte.

3 people are employed at Rivercyte.

Rivercyte is based in Erlangen, Bavaria.

Top Rivercyte Employees

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users